{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:35:11Z","timestamp":1787506511616,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74959","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:39Z","timestamp":1733120679000},"source":"Crossref","is-referenced-by-count":2,"title":["Association of Vitamin D and Prostate Health Status in Men: An Analytical Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Janvitha","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr Arul senghor","family":"K A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodhini","family":"V M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Prasath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Ravat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2377960818811773","article-title":"Prevalence, burden, and treatment of lower urinary tract symptoms in men aged 50 and older: a systematic review of the literature","volume":"4","author":"Zhang AY","year":"2018","unstructured":"Zhang AY, Xu X. Prevalence, burden, and treatment of lower urinary tract symptoms in men aged 50 and older: a systematic review of the literature. SAGE Open Nurs. 2018, 4:2377960818811773. 10.1177\/2377960818811773","journal-title":"SAGE Open Nurs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2017.1311857","article-title":"Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms\/benign prostatic hyperplasia","volume":"21","author":"Park SG","year":"2017","unstructured":"Park SG, Yeo JK, Cho DY, Park MG. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms\/benign prostatic hyperplasia. Aging Male. 2017, 21:55-9. 10.1080\/13685538.2017.1311857","journal-title":"Aging Male"},{"key":"ref3","article-title":"Vitamin D deficiency and lower urinary tract symptoms in males above 50 years of age","volume":"9","author":"Elshazly MA","year":"2017","unstructured":"Elshazly MA, Sultan MF, Aboutaleb HA, et al.. Vitamin D deficiency and lower urinary tract symptoms in males above 50 years of age. Urol Ann. 2017, 9:170-3.","journal-title":"Urol Ann"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0283","article-title":"Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis","volume":"7","author":"Song ZY","year":"2018","unstructured":"Song ZY, Yao Q, Zhuo Z, Ma Z, Chen G. Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis. Endocr Connect. 2018, 7:R294-303. 10.1530\/EC-18-0283","journal-title":"Endocr Connect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00734-2","article-title":"Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-\u03b2-catenin signaling axis and static & dynamic dual roles","volume":"29","author":"Shan S","year":"2023","unstructured":"Shan S, Su M, Li Y, et al.. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-\u03b2-catenin signaling axis and static & dynamic dual roles. Mol Med. 2023, 29:139. 10.1186\/s10020-023-00734-2","journal-title":"Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.03.016","article-title":"Reviewing the evidence on vitamin D supplementation in the management of testosterone status and its effects on male reproductive system (testis and prostate): mechanistically dazzling but clinically disappointing","volume":"42","author":"Santos HO","year":"2020","unstructured":"Santos HO, Howell S, Nichols K, Teixeira FJ. Reviewing the evidence on vitamin D supplementation in the management of testosterone status and its effects on male reproductive system (testis and prostate): mechanistically dazzling but clinically disappointing. Clin Ther. 2020, 42:e101-14. 10.1016\/j.clinthera.2020.03.016","journal-title":"Clin Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.11.005","article-title":"The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial","volume":"40","author":"Zendehdel A","year":"2021","unstructured":"Zendehdel A, Ansari M, Khatami F, Mansoursamaei S, Dialameh H. The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial. Clin Nutr. 2021, 40:3325-31. 10.1016\/j.clnu.2020.11.005","journal-title":"Clin Nutr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03722-y","article-title":"Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study","volume":"20","author":"Wang YB","year":"2022","unstructured":"Wang YB, Yang L, Deng YQ, Yan SY, Luo LS, Chen P, Zeng XT. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. J Transl Med. 2022, 20:495. 10.1186\/s12967-022-03722-y","journal-title":"J Transl Med"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.29328\/journal.acst.1001028","article-title":"Prostate health in India (BPH & prostate cancer)","volume":"6","author":"Suresh K","year":"2022","unstructured":"Suresh K. Prostate health in India (BPH & prostate cancer). Arch Cancer Sci Ther. 2022, 6:9-17.","journal-title":"Arch Cancer Sci Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.03.070","article-title":"Vitamin D deficiency as a potential marker of benign prostatic hyperplasia","volume":"97","author":"Zhang W","year":"2016","unstructured":"Zhang W, Zheng X, Wang Y, Xiao H. Vitamin D deficiency as a potential marker of benign prostatic hyperplasia. Urology. 2016, 97:212-8. 10.1016\/j.urology.2016.03.070","journal-title":"Urology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/aja202182","article-title":"Clinical application of free\/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml(-1) in Western China","volume":"24","author":"Gao XD","year":"2022","unstructured":"Gao XD, Miao Q, Zhang JL, et al.. Clinical application of free\/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml(-1) in Western China. Asian J Androl. 2022, 24:195-200. 10.4103\/aja202182","journal-title":"Asian J Androl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12092","article-title":"Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes","volume":"3","author":"Caretta N","year":"2015","unstructured":"Caretta N, Vigili de Kreutzenberg S, Valente U, et al.. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes. Andrology. 2015, 3:1062-7. 10.1111\/andr.12092","journal-title":"Andrology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/and.14410","article-title":"How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study","volume":"54","author":"Voutilainen A","year":"2022","unstructured":"Voutilainen A, Virtanen JK, Hantunen S, Nurmi T, Kokko P, Tuomainen TP. How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study. Andrologia. 2022, 54:e14410. 10.1111\/and.14410","journal-title":"Andrologia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1024\/0300-9831\/a000780","article-title":"Multiplicative, additive, and interactive associations of 25-hydroxyvitamin D with lung and prostate cancer","volume":"94","author":"Voutilainen A","year":"2024","unstructured":"Voutilainen A, Virtanen JK, Hantunen S, Nurmi T, Kokko P, Tuomainen TP. Multiplicative, additive, and interactive associations of 25-hydroxyvitamin D with lung and prostate cancer. Int J Vitam Nutr Res. 2024, 94:133-42. 10.1024\/0300-9831\/a000780","journal-title":"Int J Vitam Nutr Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.12.005","article-title":"Circulating vitamin D and selenium levels and outcome in prostate cancer patients: lessons from the MARTINI-lifestyle cohort","volume":"7","author":"Thederan I","year":"2021","unstructured":"Thederan I, Chandrasekar T, Tennstedt P, et al.. Circulating vitamin D and selenium levels and outcome in prostate cancer patients: lessons from the MARTINI-lifestyle cohort. Eur Urol Focus. 2021, 7:973-9. 10.1016\/j.euf.2020.12.005","journal-title":"Eur Urol Focus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31966","article-title":"Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer","volume":"144","author":"Yuan C","year":"2019","unstructured":"Yuan C, Shui IM, Wilson KM, Stampfer MJ, Mucci LA, Giovannucci EL. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer. Int J Cancer. 2019, 144:2401-7. 10.1002\/ijc.31966","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194591","article-title":"Increased density of growth differentiation factor-15+ immunoreactive M1\/M2 macrophages in prostate cancer of different Gleason scores compared with benign prostate hyperplasia","volume":"14","author":"Bonaterra GA","year":"2022","unstructured":"Bonaterra GA, Schleper A, Skowronek M, et al.. Increased density of growth differentiation factor-15+ immunoreactive M1\/M2 macrophages in prostate cancer of different Gleason scores compared with benign prostate hyperplasia. Cancers (Basel). 2022, 14:4591. 10.3390\/cancers14194591","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4029470","article-title":"Therapeutic effects of 25-hydroxyvitamin D on the pathological process of benign prostatic hyperplasia: an in vitro evidence","volume":"2021","author":"Chen Y","year":"2021","unstructured":"Chen Y, Xu H, Liu C, Gu M, Chen Q, Zhan M, Wang Z. Therapeutic effects of 25-hydroxyvitamin D on the pathological process of benign prostatic hyperplasia: an in vitro evidence. Dis Markers. 2021, 2021:4029470. 10.1155\/2021\/4029470","journal-title":"Dis Markers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278395-association-of-vitamin-d-and-prostate-health-status-in-men-an-analytical-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:41Z","timestamp":1733120681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278395-association-of-vitamin-d-and-prostate-health-status-in-men-an-analytical-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.74959","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}